Research method for regulating and controlling tendon repair mechanism through protease activated receptor
By screening and designing small molecule activators for specific protease receptor subtypes, establishing tendon injury models and evaluating repair effects, the problem of PRP activators in the prior art poor effect on tendon repair is solved, and more effective cells are achieved Proliferation and collagen secretion improve the quality of tendon repair.
Patent Information
- Application Number
- CN202411278066.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the platelet substances released by PRP after activation by activating agents such as thrombin or collagen have growth factors that promote angiogenesis and inhibit angiogenesis, resulting in poor repair of tendon damage and failure to specifically study the protease activation receptor. body activation and its effect on tendon repair.
By screening and designing small molecule or peptide activators for specific protease receptor subtypes, establish tendon injury models, perform grouping administration and evaluate repair effects, including histological, biomechanical and molecular biology assessments, preferred PAR1 and PAR4 As the target receptor.
This method can effectively evaluate the receptor activation and tendon repair effect, significantly promote cell proliferation and collagen secretion, and improve the quality of tendon repair.
Smart Images

Figure CN119020450A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of tendon repair, and in particular to a research method for regulating the tendon repair mechanism by activating receptors through proteases. Background Art
[0002] Tendon injury repair is mainly divided into four stages: inflammation, repair (proliferation), first remodeling (reinforcement) and second remodeling (maturation). Studies have found that the inflammation and repair stages require more angiogenesis, recruiting more cells and growth factors, and promoting massive cell proliferation and migration to repair damaged tissues; in the remodeling stage, the cell proliferation ability decreases, and the secretion of extracellular matrix is the main task of restoring and reconstructing tissue structure. Excessive angiogenesis will affect its structural reconstruction and damage the biomechanical properties of the tendon. In the prior art, the platelet release products released after PRP is fully activated by activators such as thrombin or collagen include both growth factors that promote angiogenesis and growth factors that inhibit angiogenesis, resulting in poor results for tendon injury repair.
[0003] In order to solve the above problems, after searching, a Chinese patent publication number CN117100842A discloses a composite active ingredient for treating tendon injury, and its preparation method and application, including a first active ingredient and a second active ingredient, the first active ingredient including a first platelet releaser, and the second active ingredient including a second platelet releaser; the first platelet releaser includes vascular endothelial growth factor and monocyte chemoattractant protein 1, and the second platelet releaser includes vascular endothelial cell inhibitory factor.
[0004] The above patent has the following deficiencies: it is unable to specifically study the activation of the receptor by the protease and the extent of tendon repair after the receptor activation.
[0005] To this end, the present invention proposes a research method for regulating the tendon repair mechanism by activating receptors through proteases Summary of the invention
[0006] The purpose of the present invention is to solve the shortcomings of the prior art and to propose a research method for regulating the tendon repair mechanism by activating receptors through proteases.
[0007] In order to achieve the above object, the present invention adopts the following technical solutions:
[0008] A research method for regulating tendon repair mechanism by protease-activated receptors, comprising the following steps:
[0009] S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair;
[0010] S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators;
[0011] S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model;
[0012] S4: Grouping and drug administration: grouping and drug administration of tendon injury models;
[0013] S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
[0014] Preferably: in the step S1, the PARs subtypes are PAR1 and PAR4.
[0015] Preferably: the step S2 comprises the following steps:
[0016] S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity;
[0017] S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
[0018] Preferably: the step S3 includes the following steps:
[0019] S31: Mice were selected as an animal model to determine the type and extent of tendon injury;
[0020] S32: Using surgical methods, partial or complete tendon rupture injury is caused at the site of the animal model;
[0021] S33: Precisely suture and fix the injured area.
[0022] Preferably: in step S32, the injured part is the Achilles tendon or the patellar tendon.
[0023] Preferably: in step S5, the repair effect evaluation includes histological evaluation, biomechanical evaluation and molecular biological evaluation.
[0024] Preferably, the histological evaluation comprises the following steps:
[0025] A1: The tendon tissue at the injury site was sliced and stained;
[0026] A2: Observe the regeneration of tendon tissue, collagen fiber arrangement, angiogenesis and inflammatory cell infiltration.
[0027] Preferably: the biomechanical assessment comprises the following steps:
[0028] B1: Take tendon tissue from the injured area;
[0029] B2: Use biomechanical testing equipment to perform tensile testing on the repaired tendon to measure its maximum load and stiffness.
[0030] Preferably: the molecular biological assessment comprises the following steps:
[0031] C1: Detection of growth factors, matrix metalloproteinases and their inhibitors in tendon tissue by qRT-PCR or Western Blot method;
[0032] C2: Measure changes in its expression.
[0033] Preferably, in step S22, the in vitro cell experiment is performed using flow cytometry or luciferase reporter gene detection.
[0034] The beneficial effects of the present invention are:
[0035] The present invention establishes a model and administers drugs, and then performs histological evaluation, biomechanical evaluation and molecular biological evaluation, thereby being able to well reflect the receptor activation and repair conditions. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 This is a flow chart of a research method proposed by the present invention for regulating the mechanism of tendon repair by activating receptors through proteases;
[0037] Figure 2 This is a comparison diagram of the differential effects of PAR1-PRP, PAR4-PRP and Thr-PRP on HUVECs, a research method for regulating tendon repair mechanism through protease-activated receptors proposed in the present invention;
[0038] Figure 3 a is a comparison of the effects of PRP under different treatment conditions on TSPCs cell proliferation and stemness marker gene expression. The CCK-8 method was used to detect the cell proliferation of TSPCs in different groups after 3 days of PRP treatment.
[0039] Figure 3 b qqRT-PCR experiment to determine the expression of Oct-4 and Nanog genes in TSPCs under different treatment conditions;
[0040] Figure 4 a Comparison of the effects of PRP under different treatment conditions on TSPCs collagen secretion. ELISA assay was used to detect the total collagen of TSPCs after 3 days of treatment with different PRPs;
[0041] Figure 4b Comparison of the effects of PRP under different treatment conditions on TSPCs collagen secretion. ELISA assay was used to detect the secretion of type I collagen after 3 days of treatment with different PRP. DETAILED DESCRIPTION
[0042] The technical solution of the present invention is further described in detail below in conjunction with specific implementation methods.
[0043] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected", "connected", and "set" should be understood in a broad sense, for example, they can be fixedly connected or set, or detachably connected or set, or integrally connected or set. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0044] Embodiment 1:
[0045] A research method for regulating tendon repair mechanism by protease-activated receptors, comprising the following steps:
[0046] S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair;
[0047] S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators;
[0048] S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model;
[0049] S4: Grouping and drug administration: grouping and drug administration of tendon injury models;
[0050] S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
[0051] In the S1 step, the PARs subtypes are PAR1 and PAR4.
[0052] The step S2 comprises the following steps:
[0053] S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity;
[0054] S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
[0055] In step S22, flow cytometry is used for in vitro cell experiments.
[0056] Embodiment 2:
[0057] A research method for regulating tendon repair mechanism by protease-activated receptors, comprising the following steps:
[0058] S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair;
[0059] S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators;
[0060] S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model;
[0061] S4: Grouping and drug administration: grouping and drug administration of tendon injury models;
[0062] S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
[0063] In the S1 step, the PARs subtypes are PAR1 and PAR4.
[0064] The step S2 comprises the following steps:
[0065] S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity;
[0066] S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
[0067] In step S22, the in vitro cell experiment uses luciferase reporter gene detection.
[0068] Embodiment 3:
[0069] A research method for regulating tendon repair mechanism by protease-activated receptors, comprising the following steps:
[0070] S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair;
[0071] S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators;
[0072] S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model;
[0073] S4: Grouping and drug administration: grouping and drug administration of tendon injury models;
[0074] S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
[0075] In the S1 step, the PARs subtypes are PAR1 and PAR4.
[0076] The step S2 comprises the following steps:
[0077] S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity;
[0078] S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
[0079] In step S22, the in vitro cell experiment is performed using flow cytometry or luciferase reporter gene detection.
[0080] The step S3 includes the following steps:
[0081] S31: Mice were selected as an animal model to determine the type and extent of tendon injury;
[0082] S32: Using surgical methods, partial or complete tendon rupture injury is caused at the site of the animal model;
[0083] S33: Precisely suture and fix the injured area.
[0084] In step S32, the injured part is the Achilles tendon or the patellar tendon.
[0085] Embodiment 4:
[0086] A research method for regulating tendon repair mechanism by protease-activated receptors, comprising the following steps:
[0087] S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair;
[0088] S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators;
[0089] S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model;
[0090] S4: Grouping and drug administration: grouping and drug administration of tendon injury models;
[0091] S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
[0092] In the S1 step, the PARs subtypes are PAR1 and PAR4.
[0093] The step S2 comprises the following steps:
[0094] S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity;
[0095] S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
[0096] In step S22, the in vitro cell experiment is performed using flow cytometry or luciferase reporter gene detection.
[0097] The step S3 includes the following steps:
[0098] S31: Mice were selected as an animal model to determine the type and extent of tendon injury;
[0099] S32: Using surgical methods, partial or complete tendon rupture injury is caused at the site of the animal model;
[0100] S33: Precisely suture and fix the injured area.
[0101] In step S32, the injured part is the Achilles tendon or the patellar tendon.
[0102] In step S5, the repair effect evaluation includes histological evaluation, biomechanical evaluation and molecular biological evaluation.
[0103] The histological evaluation includes the following steps:
[0104] A1: The tendon tissue at the injury site was sliced and stained;
[0105] A2: Observe the regeneration of tendon tissue, collagen fiber arrangement, angiogenesis and inflammatory cell infiltration.
[0106] The biomechanical assessment includes the following steps:
[0107] B1: Take tendon tissue from the injured area;
[0108] B2: Use biomechanical testing equipment to perform tensile testing on the repaired tendon to measure its maximum load and stiffness.
[0109] The molecular biological assessment includes the following steps:
[0110] C1: Detection of growth factors, matrix metalloproteinases and their inhibitors in tendon tissue by qRT-PCR or Western Blot method;
[0111] C2: Measure changes in its expression.
[0112] During tendon injury repair, the rapid proliferation and self-renewal of TSPCs play a very important role. Therefore, we then examined the effects of PRP under different treatment conditions on the function of TSPCs and the related molecular mechanisms. After TSPCs were treated with 20% PAR1-PRP, PAR4-PRP and Thr-PRP for 3 days, CCK8 was detected. The results showed that PAR1-PRP, PAR4-PRP and Thr-PRP groups significantly promoted the proliferation of TSPCs compared with the untreated group. At the same time, compared with the control group, PRP groups under different treatment conditions significantly increased the expression of TSPC cell stemness marker genes Oct-4 and Nanog, and the results of the Thr-PRP group were significantly higher than those of other treatment groups. These results suggest that the effects of Thr-PRP and PAR4-PRP treatment conditions on TSPC cell proliferation and stemness maintenance may be stronger than those of PAR1-PRP treatment conditions.
[0113] The sufficient production and regular arrangement of collagen are prerequisites for tendons to maintain their basic morphology and function. We used the ELISA method to compare the collagen content produced by TSPCs treated with PAR1-PRP, PAR4-PRP and Thr-PRP. The results showed that the total collagen and type I collagen contents in the PRP treatment conditions were significantly increased compared with the untreated control group. Among them, there was no significant difference in the total collagen production content of the PAR1-PRP group compared with the Thr-PRP group; the collagen production in the PAR4-PRP group was significantly lower than that in other PRP-treated groups. These results suggest that both Thr-PRP and PAR1-PRP treatment can enhance the ability of TSPCs to secrete and produce collagen, and the magnitude of this increase is higher than the effect of PAR4-PRP treatment on TSPCs.
[0114] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A research method for regulating tendon repair mechanism through protease-activated receptors. It is characterized in that The following steps are involved: S1: PARs subtype selection, screening PARs subtypes with potential promoting effects on tendon repair; S2: Preparation and screening of PARs activators, design and synthesize small molecule activators or peptide activators targeting selected PARs subtypes, and screen the activators; S3: Establishment of tendon injury model: Select an animal model and artificially injure its tendon to form a tendon injury model; S4: Grouping and drug administration: grouping and drug administration of tendon injury models; S5: Evaluation of repair effect, evaluation of the repair results after drug administration.
2. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 1, It is characterized in that In the S1 step, the PARs subtypes are PAR1 and PAR4.
3. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 1, It is characterized in that The step S2 comprises the following steps: S21: Design and synthesize small molecule or peptide activators for selected PARs subtypes with high specificity, high affinity and low toxicity; S22: Through in vitro cell experiments, screen out PARs activators with good activation effects.
4. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 1, It is characterized in that The step S3 includes the following steps: S31: Mice were selected as an animal model to determine the type and extent of tendon injury; S32: Using surgical methods, partial or complete tendon rupture injury is caused at the site of the animal model; S33: Precisely suture and fix the injured area.
5. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 4, It is characterized in that In step S32, the injured part is the Achilles tendon or the patellar tendon.
6. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 1, It is characterized in that In step S5, the repair effect evaluation includes histological evaluation, biomechanical evaluation and molecular biological evaluation.
7. A research method for regulating tendon repair mechanism by protease-activated receptors according to claim 6, It is characterized in that The histological evaluation The following steps are involved: A1: The tendon tissue at the injury site was sliced and stained; A2: Observe the regeneration of tendon tissue, collagen fiber arrangement, angiogenesis and inflammatory cell infiltration.
8. The method of claim 6 for regulating the mechanism of tendon repair by protease-activated receptors, It is characterized in that The biomechanical assessment The following steps are involved: B1: Take tendon tissue from the injured area; B2: Use biomechanical testing equipment to perform tensile testing on the repaired tendon to measure its maximum load and stiffness.
9. The method of claim 6 for regulating the mechanism of tendon repair by protease-activated receptors, It is characterized in that The molecular biological assessment includes the following steps: C1: Detection of growth factors, matrix metalloproteinases and their inhibitors in tendon tissue by qRT-PCR or Western Blot method; C2: Measure changes in its expression.
10. According to the research method for regulating tendon repair mechanism by protease-activated receptors as described in claim 3, in step S22, the in vitro cell experiment adopts flow cytometry or luciferase reporter gene detection.
